Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome
Ann Intern Med
.
2020 Apr 7;172(7):509-510.
doi: 10.7326/L20-0052.
Authors
Derek Leong
1
,
Peter E Wu
1
Affiliation
1
University Health Network, University of Toronto, Toronto, Ontario, Canada (D.L., P.E.W.).
PMID:
32252074
DOI:
10.7326/L20-0052
No abstract available
Publication types
Comment
MeSH terms
Anticoagulants
Antiphospholipid Syndrome*
Factor Xa Inhibitors
Humans
Rivaroxaban*
Vitamin K
Substances
Anticoagulants
Factor Xa Inhibitors
Vitamin K
Rivaroxaban